Login
Companies $HIMS
$18.55 -$0.01 (0.07%) After hours
Hims & Hers Health, Inc. logo

Hims & Hers Health, Inc.

Compare classes
forhims.com

What Do They Do?

Provides consumers with digital clinical care, prescription and nonprescription treatments, and laboratory testing, and sells nonprescription wellness products to retailers.

How Do They Make Money?

Individuals buy health and wellness products and services online; most online sales are subscriptions billed on the customer’s selected shipment cadence, while some are one-time purchases. Retailers buy nonprescription products through wholesale agreements.

FY2025 revenue

Who Are Their Customers?

Most customers are individuals buying through the company’s websites or apps. Retailers buy nonprescription products under wholesale agreements, and sales also go through third-party platforms.

Do Revenues Turn Into Profits?

Yes. It kept 5 cents of every revenue dollar as net income in FY2025 and turned 2 cents into free cash flow.

Operating income, FY2025
4% of revenue
▲ +71% vs FY2024 ($61.9M, 4%)
Net income, FY2025
5% of revenue
▲ +2% vs FY2024 ($126M, 9%)
Free cash flow, FY2025
2% of revenue
▼ −71% vs FY2024 ($198.3M, 13%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +49%
vs $599M in Q3 FY2025
Net income
▼ Turned to a loss
vs $15.8M in Q3 FY2025
  • Nov 9, 2026 Company tightened revenue guidance and reduced adjusted EBITDA guidance Full-year revenue guidance is $3.13 billion to $3.15 billion, and adjusted EBITDA guidance is $257 million to $277 million.
  • May 29, 2026 Hims & Hers completed its acquisition of Eucalyptus The deal extends the company’s reach into Australia and Japan and deepens its presence in the United Kingdom, Germany and Canada.

Growing. Revenue grew 8.6x in 4 years, from $271.9M in FY2021 to $2.3B in FY2025, about 71% a year.

Specialty expansion The older report listed testosterone, menopause and weight management as future opportunities; the latest says the company offers hormone and weight-loss care and launched testosterone, menopause and perimenopause support.

International expansion The older report described expansion in the United Kingdom and further international opportunities as a goal; the latest says the company has established operations in the United Kingdom, parts of the European Union and Canada.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support